FLGT
Fulgent Genetics Inc

5,737
Mkt Cap
$896.46M
Volume
354,226.00
52W High
$30.59
52W Low
$14.57
PE Ratio
-20.69
FLGT Fundamentals
Price
$28.78
Prev Close
$29.00
Open
$29.17
50D MA
$23.75
Beta
0.81
Avg. Volume
200,783.22
EPS (Annual)
-$1.41
P/B
0.79
Rev/Employee
$215,894.90
Loading...
Loading...
News
all
press releases
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded Fulgent Genetics from a "hold" rating to a "buy" rating in a research report on Saturday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month High - Still a Buy?
Fulgent Genetics (NASDAQ:FLGT) Reaches New 52-Week High - What's Next...
MarketBeat·6d ago
News Placeholder
Connor Clark & Lunn Investment Management Ltd. Increases Stake in Fulgent Genetics, Inc. $FLGT
Connor Clark & Lunn Investment Management Ltd. increased its stake in Fulgent Genetics, Inc. (NASDAQ:FLGT - Free Report) by 22.2% in the second quarter, according to its most recent 13F filing with...
MarketBeat·7d ago
News Placeholder
Piper Sandler Issues Positive Forecast for Fulgent Genetics (NASDAQ:FLGT) Stock Price
Piper Sandler increased their target price on shares of Fulgent Genetics from $21.00 to $30.00 and gave the stock a "neutral" rating in a research note on Tuesday...
MarketBeat·8d ago
News Placeholder
Fulgent Genetics (NASDAQ:FLGT) Announces Quarterly Earnings Results, Beats Expectations By $0.36 EPS
Fulgent Genetics (NASDAQ:FLGT - Get Free Report) announced its quarterly earnings results on Friday. The company reported $0.14 EPS for the quarter, beating analysts' consensus estimates of ($0.22...
MarketBeat·11d ago
News Placeholder
Fulgent Genetics (NASDAQ:FLGT) Sets New 12-Month High on Earnings Beat
Fulgent Genetics (NASDAQ:FLGT) Hits New 52-Week High on Better-Than-Expected Earnings...
MarketBeat·12d ago
News Placeholder
Fulgent to Participate in Upcoming Conferences
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent, or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...
Business Wire·13d ago
News Placeholder
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates
Fulgent Genetics (FLGT) delivered earnings and revenue surprises of +158.33% and +3.47%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·13d ago
News Placeholder
Fulgent Reports Third Quarter 2025 Financial Results
Fulgent Genetics, Inc. (NASDAQ: FLGT) (Fulgent, or the Company), a technology-based company with a well-established laboratory services business and a therapeutic development business, today...
Business Wire·13d ago
News Placeholder
Evolent Health (EVH) Misses Q3 Earnings Estimates
Evolent Health (EVH) delivered earnings and revenue surprises of -50.00% and +2.81%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·14d ago

Latest FLGT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.